What is WAVE Life Sciences 3-Year EBITDA Growth Rate?
WAVE Life Sciences's EBITDA per Share for the
three
months ended in Dec. 2023 was $-0.15.
During the past 3 years, the average EBITDA Per Share Growth Rate was 46.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 35.10% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -16.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of WAVE Life Sciences was 46.70% per year. The lowest was -149.30% per year. And the median was -16.75% per year.
Competitive Comparison of WAVE Life Sciences's 3-Year EBITDA Growth Rate
For the Biotechnology subindustry, WAVE Life Sciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WAVE Life Sciences's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, WAVE Life Sciences's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where WAVE Life Sciences's 3-Year EBITDA Growth Rate falls into.
WAVE Life Sciences 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
WAVE Life Sciences (NAS:WVE) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
WAVE Life Sciences 3-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of WAVE Life Sciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
WAVE Life Sciences (WAVE Life Sciences) Business Description
WAVE Life Sciences Ltd is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WVE has been successfully added to your